PARP15 | OmnibusX

Name	Number of supported studies	Average coverage
B cell	22 studies	30% ± 8%	Explore
memory B cell	16 studies	25% ± 6%	Explore
naive B cell	13 studies	26% ± 8%	Explore
CD16-positive, CD56-dim natural killer cell, human	11 studies	20% ± 4%	Explore
natural killer cell	7 studies	21% ± 2%	Explore
precursor B cell	4 studies	28% ± 4%	Explore
immature B cell	4 studies	32% ± 4%	Explore
mature NK T cell	3 studies	17% ± 1%	Explore
CD8-positive, alpha-beta T cell	3 studies	19% ± 3%	Explore

sc-RNAseq data

Insufficient scRNA-seq data for expression of PARP15 at tissue level.

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
lung	100%	1425.87	578 / 578	78%	3.98	900 / 1155
stomach	94%	294.36	339 / 359	60%	2.00	172 / 286
esophagus	88%	235.52	1265 / 1445	63%	2.38	116 / 183
thymus	92%	523.62	601 / 653	52%	1.88	315 / 605
intestine	97%	1827.08	933 / 966	47%	1.66	250 / 527
breast	91%	296.18	419 / 459	52%	1.73	584 / 1118
uterus	90%	209.18	153 / 170	44%	1.12	202 / 459
bladder	90%	320.29	19 / 21	42%	1.29	212 / 504
liver	94%	281.18	213 / 226	27%	0.84	109 / 406
kidney	65%	252.73	58 / 89	48%	1.37	433 / 901
prostate	88%	284.11	216 / 245	15%	0.36	76 / 502
pancreas	30%	45.77	99 / 328	72%	3.22	128 / 178
spleen	100%	11045.97	241 / 241	0%	0	0 / 0
adipose	98%	540.33	1183 / 1204	0%	0	0 / 0
peripheral blood	98%	3009.26	910 / 929	0%	0	0 / 0
lymph node	0%	0	0 / 0	93%	20.06	27 / 29
adrenal gland	82%	176.34	212 / 258	5%	0.08	11 / 230
skin	32%	56.85	584 / 1809	44%	2.43	207 / 472
heart	67%	134.75	580 / 861	0%	0	0 / 0
tonsil	0%	0	0 / 0	64%	2.56	29 / 45
ovary	33%	58.91	59 / 180	24%	0.41	104 / 430
blood vessel	50%	195.33	673 / 1335	0%	0	0 / 0
muscle	39%	80.14	311 / 803	0%	0	0 / 0
brain	9%	15.04	250 / 2642	18%	0.44	130 / 705
eye	0%	0	0 / 0	8%	0.16	6 / 80
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0
ureter	0%	0	0 / 0	0%	0	0 / 1

GO_0070212	Biological process	protein poly-ADP-ribosylation
GO_0000122	Biological process	negative regulation of transcription by RNA polymerase II
GO_0010629	Biological process	negative regulation of gene expression
GO_0005737	Cellular component	cytoplasm
GO_0005634	Cellular component	nucleus
GO_0016779	Molecular function	nucleotidyltransferase activity
GO_0070403	Molecular function	NAD+ binding
GO_1990404	Molecular function	NAD+-protein ADP-ribosyltransferase activity
GO_0003950	Molecular function	NAD+ ADP-ribosyltransferase activity
GO_0003714	Molecular function	transcription corepressor activity
GO_0005515	Molecular function	protein binding

Gene name	PARP15
Protein name	Protein mono-ADP-ribosyltransferase PARP15 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 7) (ARTD7) (B-aggressive lymphoma protein 3) (Poly [ADP-ribose] polymerase 15) (PARP-15) Poly [ADP-ribose] polymerase (PARP) (EC 2.4.2.-)
Synonyms	BAL3
Description	FUNCTION: Mono-ADP-ribosyltransferase that mediates mono-ADP-ribosylation of target proteins . Acts as a negative regulator of transcription . .
Accessions	ENST00000464300.7 [Q460N3-1] B7ZL48 C9J7L3 Q460N3 ENST00000493645.1 ENST00000310366.8 [Q460N3-2] ENST00000483793.5

PARP15 report